Engineered Red Blood Cells Carrying PCSK9 Inhibitors Persistently Lower LDL and Prevent Obesity
R. Deshycka, V. Sudaryo, N.-J. Huang, Y. Xie, L. Y. Smeding, M. K. Choi, H. Ploegh, H. Lodish, N. Pishesha
This study develops engineered red blood cells expressing a PCSK9 inhibitor to lower LDL and prevent obesity in mice.
bioRxiv · Nov 2, 2020Bioengineering